Iaso Ventures

01/13/2022

Iaso Ventures teams up with Haynes and Boone, LLP to launch a new podcast series on trends in precision medicine.

We are proud to present the Precision Medicine Thought Leader Series, a recurring podcast series by the lawyers in Haynes Boone’s practice and Iaso Ventures that will discuss novel technological and legal developments in healthcare and life sciences. For our inaugural episode, we are joined by Wasim Malik of Iaso Ventures to discuss neuroscience and Iaso’s contribution to developing neuroscience-based technologies in healthcare. Watch now: https://lnkd.in/eHZMR_KU or listen here: https://lnkd.in/eZxEAveJ

04/13/2021

Altimate Health, Massachusetts General Hospital Sign Agreement to Advance Precision Psychiatry Tuesday, April 13, 2020 Altimate Health Corporation and Massachusetts General Hospital announced that they have signed a collaboration agreement for joint research, development, and commercialization in th...

11/19/2020

We are delighted to announce our strategic partnership with Haynes and Boone, LLP.

Haynes and Boone and Iaso Ventures announce on Nov. 19 that they have formed a new alliance to provide strategic advice and best practices to companies. Both firms have deep experience serving the neuroscience and behavioral health sectors and are teaming to expand the scope of education and services that they can provide to startups. - http://ow.ly/G5VZ50CpAjZ

10/13/2020

Join us to explore the Rhode Island ecosystem and how it can support Med Tech ventures’ development, growth, and fundraising goals.

08/17/2020

Iaso Ventures portfolio company Altimate Health has a new paper out on improving outcomes through data-driven prediction of relapse in substance use disorders. As this clinical study shows, by predicting a potentially catastrophic relapse event well in advance, one can intervene and prevent its occurrence, thus directly saving human lives.

https://www.medrxiv.org/content/10.1101/2020.08.10.20163881v1.full.pdf

06/25/2020

The Wall Street Journal today features Iaso Ventures in discussing the edge of sector-specific VC funds

A growing number of health-care venture-capital firms are taking specialization to an extreme, raising funds targeting a single medical field, such as cancer, ophthalmology, cardiology or neuroscience.

06/16/2020

Meet the 2020 : Iaso Ventures a full-service building and -based, -centered growth programmer early companies, targeting , , abuse and disorders.

03/23/2020

Announcing Iaso Venture Studio, a 12-month program for early-stage startups working on in , , and . Please share with companies in stages from concept through Series A.

Visit www.iasoventures.com/studio for details.

01/29/2020

In the U.S. one in four adults struggle with it.

01/09/2020

Iaso Ventures team members will be speaking at various events during in San Francisco. Please attend and get in touch to set up meetings.

Meet us at JPM 2020 admin January 8, 2020 Events 0 Comments Dr. Valerie Photos will be moderating a panel on New Trends in Early Stage Ventures at the IvyFON San Francisco Family Office Outlook Forum on Jan 15th during the JP Morgan Health Conference 2020. The panelists will be with Carlos S. Barade...

09/11/2019

Wasim will be speaking about digital health investing at the RESI conference tomorrow at 10am. Please join us!

Digital Health Investors This panel focuses on investing in innovative digital health products that bring new efficiencies to the healthcare system, change how care is delivered or managed, and how patients are involved in their own care. Panelists will explore topics related to investing in digital...

07/30/2019

Astute blog post by our advisor Craig DeLarge, of The Digital Mental Project, observing the landscape of investment firms with an interest in behavioral health. Iaso Ventures is glad to be recognized as a center of excellence for early-stage neuroscience and behavioral healthtech.

Pure-play Investors In my getting around in MentalTech circles talking with founders and implementors, I am often asked the question, “Do…